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Summary
Demogtaphic data of the Greek haemophiha A and B population
for the penod 1972-1993 were analyzed Pievalence at buth includmg
known not-registeied patients was calculated at 23 l pei 100,000
male births However, the obseived prevalence m 1993 was only 61%
of the expected Smce 1975 the propoition of mild cases had sigmfi-
cantly mcreased Adjusted by age, seventy and HIV Status leproductive
fitness of haemophihacs was 062 Overall moitahty was 26 times
highei than in the geneial population, but 7 9 times among patients with
seveie haemophiha and 16 4 among HIV(+) haemophihacs Fifty out of
78 deaths occuired among HIV(+) patients and 28 of these were caused
by AIDS Inhibitoi patients did not show excess moitahty due to
bleeding Cancei mortahty was equal to noimal, but the number of
deaths fiom ischaemic heart disease was 0 25 of the expected Risk of
death due to cerebial haemonhage was 3 8 times highei m HIV(+)
haemophihacs than m HIV(-)
Introduction
The Haemophilia Treatment Centie of Laikon Hospital (HTCLH),
Athens, prov:des care for 72% of Greek haemophiha A and 81% of
Greek haemophiha B patients (1) and is one of the largest Eiuopean
haemophiha centtes This survey with infoimation about 531 patients
and their families covers a twenty-one-yeai penod (1972-1992) and
has the aim to estimate the pievalence of the disordei, the lepioductive
fitness of haemophihacs and the mortahty and causes of death ot this
group In the moitahty figures, the impact of HIV mfection is de
scnbed
It is important to note that since 1960 Greek haemophihacs have
started to be treated systematically with fiesh-frozen plasma Lyophi-
hzed ciyoprecipitate of national ongm was intioduced m 1969 and
PPSB m 1973 Factoi VIII and later Factoi IX concentrates weie
mitially impoited only foi majoi suigeiy and smce 1980-81 foi loutine
use In Septembei 1985 virus mactivated concentiates leplaced all
previous pioducts Inteimediate and high punty concentiates äs well äs
FVIII punfied by monoclonal antibody techmques aie now used foi
Substitution therapy Dunng the last 5 yeais of the study the mean FVIII
consumption was 12,500 IU annually per haemophihac (24,000 IU foi
actively treated patients) Home treatment staited eveismce 1972 and it
was spiead to all patients that would benefit from it durmg the study
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penod Fmally, it is noteworthy that piophylactic treatment has never
been used routmely m oui centre (1)
The observed increasing pievalence of haemophiha, the mcieased
patients aveiage age and the changes in the death causes are factors that
leflect the achievements of the last decades m the management of
haemophiha and would be helpful if taken under consideration for
planmng of future haemophiha care
Patients and Methods
Pievalenie
In estimatmg the pievalence at birth one has to account for underestimatmg
because of dealhs and delayed diagnosis (2) A fnst approach is to piepare a
cuive of the actual pievalence (number of hvmg patients/number of living
males) in all age gioups, which will show a plateau m the first decades of adult
hood This will yield a fair estimate if excess moitahty is not too high, but will
still be an undeiestimate Heie we attempted a direct approach we searched to
count all patients bom m the penod 1952-1976, and divided the final numbei
by all males bom m this penod m Gieece This penod, with patients now lang
mg m age fiom 15 to 40 (if still ahve) was chosen to mimmize the effects of
delays m diagnosis and registiation befoie age 15, and of high excess mortahty
m oldei patients Fnst, we made a table of all oui legisteied patients (dead and
ahve) born in this penod Subsequently we conducted family studies in 148 pe-
digrees to identiiy umegisteied patients (dead or ahve) which showed that our
legisüy had a completeness of 85% in haemophiha A and 81% m haemophiha
B In addition, we know that 28% of haemophiha A, and 19% of haemophiha
B patients aie legisteied m other cenües Fmally, with these figuies we extia
polated fiom the patients legisteied in our centre, to all patients bom m Greece
between 1952 and 1976 by a piopoitional extension The estimation of the
obseived prevalence was based on the same method, apart from the fact that m
the table we mcluded only patients ahve m the beginnmg of 1993
Fitness
Data for 318 patients bom m the penod 1931-1970 were used for the esti-
mation of the lepioductive fitness of haemophihacs The numbei of their
offspnng until 31 12 92 denved from family studies Haemophihacs who died
befoie leachmg genetic matunty (under age 15) were mcluded m the final fit
ness calculation smce they represent haemophilic genes lost All patients were
divided in thiee gioups accoidmg to seventy and in foui subgroups accoidmg
to the decade of then bn th The mean number of childi en of the patients m each
age gioup was compared to the expected number foi that age group based on
figuies foi the geneial male population (3) The ratio of the obseived numbei of
childien summed over all age gioups, and of the expected numbei summed over
all age gioups is the age-standardized fitness The observed number of children
was adjusted for HlV-status and seventy pnor to this companson, to allow for
mcomplete data in some of the patients seen less frequently [i e HIV(-) pa
tients, mild haemophiha] and not mcluded m the study Complete data on fami
ly size weie available foi 82% of our centie's patients Obviously, for vanous
leasons HIV Status and seventy affect fitness
Mortahty, Life Expectancy, Causes ofDeath
The follow-up covers the penod from 1-1-1972 to 31-3-1993 Sixty-two
patients with mild haemophiha (mean FVIII C approximately 11 lU/dl) ongi-
natmg from the village Aiani of Macedonia and sharmg the same mutation (4)
formed a special category The patient-yeai method was used for the calcula-
tion of Standardized Mortahty Ratios (SMR), which compare the observed to
the expected number of deaths, based on the population moitahty rates The
expected mortahty was adjusted for age, sex and calendar penod The calcula-
tion of confidence mtervals was based on a Poisson distnbution Smce for
several reasons mfant moitahty in haemophihacs may be underestimated (5, 6)
we decided to exclude mfant mortahty m both patients and population figures
Therefore, when registration year was the year of birth, entry m the study group
was one yeai later The eight age groups used weie 1-19, 20-29, , 70-79 and
over 80 years old The same calculations were made for the group of HIV(+)
patients startmg from the approximate mean seroconversion date (1-1-1983)
The causes of death were m almost all cases certified by HTCLH physicians
Autopsies were generally not perfoimed Cause-specific mortahty foi deaths
due to cancer and ischaemic heart disease were calculated with cause-specific
population mortahty lates Fmally, aftei an initial obseivation of excess moi-
tahty due to cerebi al haemoi rhage of HIV(+) patients over HIV(-), we estimat-
ed the mcidence of fatal cerebral bleedmg m both groups adjusted foi age and
seventy Patient-yeais for HIV(+) and HIV(-) Status were calculated usmg 1-1-
1983 äs the seroconversion date for HIV(+) patients Obviously, these patients
contnbuted patient-time to both HIV(-) patient-yeais (befoie 1-1-83) and
HIV(+) patient-yeais (aftei 1-1-83) A Poisson legiession model was used to
estimate the mcidence late ratio foi fatal ceiebral bleedmg m HIV(+) and
HIV(-) Status adjusted for age and seventy The results were expiessed äs täte
ratios, relative for each variable to the lowest (refeience) categoiy
Definition!
Patients were grouped by seventy accoidmg to FVIII C 01 FIX C levels,
seveie clottmg activity <1 lU/dl, moderate clottmg activity 1-5 lU/dl, mild
clottmg activity 5-25 lU/dl Haemophiha B Leiden patients weie consideied äs
mild cases Von Willebrand disease was excluded by appiopnate testmg
Coagulation measuiements weie perfoimed by standaid techniques We
Table l Prevalence at birth and observed pievalence of haemophiha m the Greek population
Type and seventy
Severe
Moderate
Mild
A
All
Severe
Moderate
Mild
No of haemophihc
mfants born m the
penod 1952-76
144
54
178
376
46
12
14
Prevalence
pei 100,000
male births
74
28
92
193
24
06
07
No of
haemophihacs
ahveinl-3-1993
181
108
317
606
53
27
21
Observed
prevalence per
100,000 males
36
2 1
63
120
1 1
05
04
All 72 37 101 20
The prevalence at birth is calculated by the number of males born ahve m Greece between 1952 and 1976 The total prevalence pei 100,000 male births by sev-
enty is severe 9 8 (42%), moderate 3 4 (15%) and mild 9 9 (43%)
The observed prevalence is calculated accordmg to the Greek male population m the 1991 census The total prevalence per 100,000 males by seventy is severe 4 6
(33%), moderate 2 7 (19%) and mild 6 7 (48%)
Table 2 Reproductive fitness of haemophiha A & B patients by penod of birth and seventy
Seventy
S
E
V
E
R
E
M
0
D
E
R
A
T
E
M
I
L
D
Penod of birth
1931-1940
1941-1950
1951-1960
1961-1970
1931-1940
1941-1950
1951-1960
1961-1970
1931-1940
1941-1950
1951-1960
1961-1970
Patients/births
31/29
24/20
50/21
50/ 3
16/18
13/ 9
14/ 5
17/ 1
29/59
23/41
29/41
22/ 2
Ratio of births
observed/expected
046
042
030
018
056
038
024
018
101
089
095
028
Fitness
037
041
093
809
consideied äs legisteied only male patienls with a known vital Status mcluding
dates ofbnth and death, type and seventy of haemophiha In this way about 5%
of patients weic excluded fiom the study foi mcomplete data
Results
At l 3-93 theie weie 707 Greek haemophilia patients on a total po-
pulation of 5 05 imlhon Gieek males, i e obseived pievalence was
14 0 pei 100,000 males - 12 0 in haemophiha A, 2 0 in haemophiha B
(Table 1) Among these patients 619 weie legisteied (453 m oui centie
and 166 elsewheie) and 88 (12%) weie known not legistered patients
It also follows that observed pievalence of seveie haemophiha was one
out of 21,500 males The oveiall pievalence at buth was 23 l pei
100,000 male bnths, 65% highei than the obseived prevalence This
imphes that one out of 5,200 males is boin with haemophiha A and one
out of 27,000 males with haemophiha B
Infoimation about lepioductive fitness toi patients boin befoie 1970
is given m Table 2 The oveiall fitness, standaidized foi age, was 0 62
(318 patients had 249 cmldien, wheieas 402 childien weie expected on
population figuies) Foi HIV(+) patients fitness was 0 47 Since 1987
none of the HIV(+) patients has lepioduced The ditfeience m numbei
of offspring compaied with the geneial male population was most
pionounced toi the youngei geneiations (fitness by penod ofbnth was
foi 1931-1940 067, 1941-1950 062, 1951-1960 055 and
1961-1970 021)
Table 3 Geneial charactenstics of patients of HTCLHiegistiy (n = 531)
N (%)
Type
Haemophilia A
Haemophiha B
460
71
(87)
(13)
Seventy
HI V Status2
Inhibiloiλ
Yeai of biith
Seveie
Modeiate
Mild1
1900-1930
1931-1940
1941-1950
1951-1960
1961-1970
1971-1980
1981-1991
212
92
227
156
375
453
50
61
77
121
90
97
35
(40)
(Π)
(43)
(29)
(81)
( 7)
(93)
'62 patients wilh mild haemophilia had a common ancestoi oiigmating fiom
the village Aiam öl Macedoma Foui patienls aie haemophilia B Leiden
'HIV beropOMtivity is much lowei among haemophiha B patients (8%) and dif-
feis consideiably by seventy (seveie 62%, modeiate 28%, mild 8%)
3No haemophiha B patient developed mhibitoi and only 14 patients (3% of the
haemophiha A population) out of 38 weie high lespondeis, i e developed non
üansient mhibitois (anamnestic lesponse with tities ovei 10 BU/ml)
Conceimng moitahty, we followed 531 individuals (the geneial cha
lactenstics of that population are descnbed m Table 3) foi a total of
8641 peison-yeais We obseived 78 deaths (Table 4), while 30 weie ex-
pected based on age and sex adjusted population lates [SMR 2 6 with
95% confidence mteivals (C l ) of 2 l to 3 3] Moitahty was almost
8 times highei m patients with seveie haemophiha than m the general
population and the majonty of deaths - 54 - occuned among patients of
this gioup On the contiaiy, patients with mild and modeiate haemo
phiha did not expenence excess moitahty (SMR about 1) Moitahty
was by fai the highest in HIV(+) haemophihacs aftei the mean date of
mfection (SMR 16 4) Of the 78 deaths m oui cohoit, 50 occuned m
HIV(+) patients [32% of the 156 HIV(+) patients had died] It should be
emphasized that among HIV(-) patients with modei ate and mild hae
mophiha we obseived no death undei the age of 48 and among the
62 patients oiigmating fiom the Aiam village only one patient had died
The mean age of death of oui patients was 44, while m seveie haemo
phiha it was 39 and m mild haemophiha 53 Life expectancy foi HIV(-)
patients appeaied to be almost noimal
The most common cause of death among oui patients was AIDS
(Table 5) Ceiebial haemonhage followed m fiequency and was the
commonest cause among HIV(-) patients Othei types of bleedmg
weie lesponsible foi only 8 deaths Among the 38 mhibitoi patients
only one high lespondei died fiom bleedmg m 1983 Howevei, 7 moie
patients of this gioup died due to vual diseases (five by AIDS, two by
hvei diseases) SMR foi deaths due to mahgnancies was 0 83 with 95%
C I of 0 3 to l 8 Only one patient died due to ischaemic heart disease
mstead of foui expected Consequently, the SMR foi that cause was
025 with 95% C I of 00 t o i 4
The moitahty by ceiebial haemonhage was found 5 0 times highei
m HIV(+) than m HIV(-) haemophihacs, i e 8 m the 7210 patient-
yeais of the HIV(-) group and 8 in the 1431 patient yeats of the HIV(+)
gioup The incidence of death by ceiebial bleedmg was almost the
same - 5 5 pei 1,000 patient yeais - in all thiee seventy gioups among
HIV(+) haemophihacs, while in HIV(-) patients it vaned fiom 0 4 m
mild cases to l 6 in modeiate and seveie Smce the HIV(+) patients
diffeied m seventy of haemophiha and age distnbution fiom the
HIV(-) patients, we adjusted toi these vanables by multivanate Pois
son legiession This showed that each increase in seventy (mild to
modeiate, modeiate to seveie) doubled the nsk of death fiom ceiebial
haemonhage (Table 6), while each 10-yeai inciease m age led to l 5
mcieased nsk Most impoitantly, aftei this coirection, the nsk of
HIV(+) individuals still was 3 8 times äs high äs foi HIV(-) patients
Discussion
It is obvious that the lesults öf this study aie much colomed by HIV
mfection The modeiate use ot impoited commercial concentiates on
one hand and the peisistence m stiictly pioviding "on demand" substi
tution theiapy on the other, have lesulted m a medium numbei of seio
positive patients m Gieece (29%) compaied to Geimany (53%), France
(50%) and United Kingdom (39%), wheie highei pievalences of HIV
antibodies among haemophihacs have been obseived (7-9), and to The
Netheilands (17%), Belgium (4%) and Fmland (l 5%), where the pie-
dommant use of plasma pioducts fiom local nonpaid donois (10, 11)
explams the low numbei s of mfected patients Of couise, the peicen
tages given aie not completely compaiable smce diffeient methods
have been apphed foi the calculations
A compauson of the piesent study with a lepoit foi the Gieek hae
mophiha population m 1975 (12) shows a consideiable inciease in the
obseived pievalence of haemophiha (140 veisus 86 pei 100,000
810
Table 4 Moitality by seventy and HIV Status
Group
A
L
L
H
I
V
(+)
Severe
Moderate
Mild
Total
Severe
Moderate
Mild
Total
Patient
years
(yrs)
4072
1565
3003
8641
1010
256
175
1443
Standardized
moitality
ratio '
79
12
09
26
179
147
114
164
95%
confidence
mteivals
60-104
06-22
05-16
21-33
12 7-24 5
4 8-34 3
4 2-24 6
122-216
Numbei
of deaths
54
11
13
78
39
5
6
50
'Expected moitality based on national Greek moitality lates of 1970, 1975 1980 and 1985 m 5 yeais age classes Therefoie, lates are adjusted foi age, sex and
calendar penod
Table 5 CausesofdeathofHTCLHregisteredpatientsbetween l l 1972 and
31 3 1993
Cause of death
AIDS
Cerebral haemonhage
Bleedmg
Liver diseases
Cancei
Heart diseases
Other1
Unknown
Total
N
28
16
8
6
6
4
6
4
78/531
N o f H I V ( + )
28
8
2
5
2
3
2
0
50/156
'Pneumonia 2, diabetes l, encephahtis l, lenal failure l, suicide l
Table 6 Poisson regression analysis of cerebial haemoirhage deaths
Variable
Mild
Modeiate
Severe
Agegroup2
HIV Status3
Rate ratio
1 0 '
26
39
15
38
95% confidence
mtervals
04-154
08-196
12-20
13-107
1
 Reference category
210 year age groups
3
 HI V (-) äs reference category
males), but a shght reduction (from 5 l to 4 6) among severe patients,
probably due to the AIDS epidemic and the satisfactory registry m this
gioup, already by 1975 On the contraiy, the rapid growth of mild pa-
tients population (from 2 0 to 6 7) is a result of mcreased registry and
reduced moitality Mild haemophihacs now represent almost half of the
total number of patients compared to 23% m 1975 A similar develop
ment was observed m Sweden (13) between 1960 and 1980 (fiom 35%
to 54%) The total pievalence at birth (23 l per 100,000 male births), is
dose to 20 6 calculated for the Dutch population (2) and to 17 8 re
sulüng by apphcation of the plateau method to Swedish data (13) Oui
estimation is shghtly higher, which may be explamed by our effoits to
mclude known, not legistered patients by family studies, which was not
attempted in the other studies Without this correction, our esümation
becomes 19 5 per 100,000 The calculation of prevalence at buth re-
quires exüapolations that will have müoduced some erroi It is hkely
that, despite all effoits, some patients were not counted, e g those who
were never diagnosed Therefoie, we still think this estimate to be a
shght underestimate
If the sarae prevalence äs at birth was observed in each age group,
the Greek haemophihc population, whtch is now estimated at 707 pa-
tients, would have consisted of 1161 mdividuals The deficit of 39% is
higher than the leported fiom The Netheilands (22%) and Sweden
(23%) (2,13) Several explanations may be offeied i) Even elementary
haemophiha caie started to be provided in Greece later than the most
Western Euiopean countnes, which may have led to higher deficit in
older age groups because of early deaths u) Many patients are still not
registered, which depnves them from specialist care m) Deaths due to
AIDS (not tncluded in the previous studies) iv) Moie women in
Greece tend to choose foi prenatal diagnosis and selective abortion than
Dutch and Bntish women (2, 14) Greek women are more accustomed
to the idea of "pregnancy termmation", because of the high pievalence
of thalassaemia heterozygotes and the legalization of abortion ten yeais
ago Generally, it seems that the deficit between obseived prevalence
and pievalence at birth will not be elimmated m the Greek population
(leading to a significant mcrease in the number of haemophihacs) so
soon äs was foteseen for the Dutch haemophihacs (2) An additional
reason foi that is the higher HIV(+) percentage, not so much äs a cause
of a temporary mcreased excess moitality, but because of its effects m
the reproductivity of our population, which may reduce on a long term
basis the number of obligate cainers Conclusively, no mciease of
haemophiha prevalence is expected for the followmg decades, while
the percentage of mild patients will contmue to giow
Since 1947, when Haldane (15) calculated fitness of haemophihacs
to be 0 28, several studies have been published on that subject Accord-
mg to Francis and Kasper (16) haemophihacs with clottmg activity
less than 2% of the normal showed in the penod 1940-1977 a leproduc-
811
tivity late 43% of the expected We found a fitness of 0 62 for Greek
haemophiba patients bom aftei 1930 This may leflect impiovement m
care m recent peuods Cultuial diffeiences are also impoitant, e g the
patient's view concernmg the bnth of daughter carners Lately, a Hun-
gaiian study (17) has reported a fitness of 0 3 for haemophilia A and 0 8
for haemophilia B, which was, however, based on a lelatively small
number of patients In The Netherlands fitness for hvmg haemophilia
patients was 0 70 (18), similar to the piesent study if patients who died
under 15 would have been excluded Finally, the lower fitness of the
younger generations may be explamed by the mfluence ot the HIV in
fection m haemophihacs reproductivity aftet 1986, äs well äs by theu
delay m the age of marnage (16,17)
Before the mtroduction of Substitution theiapy the cause of deaths
among haemophihacs was, almost unvanably, bleedmg The low num-
ber of deaths due to all types of bleedmg, except cerebral haemonhage,
m this study proves the improvement m the etfectiveness of the provid-
ed care Nowadays, haemophihacs aie giowmg older and survive to
expenence diseases of the eldeily hke cancer and ischaemic heart
disease However, these have not yet become the commonest death
causes because of the appearance of transfusion tiansmitted viral dis-
eases Already üom 1975,77% of polytransfused Greek haemophihacs
were infected by the hepatitis B virus (12) and 47% had abnormal hver
function tests (19) In the present study 8% of deaths weie leported to
be caused by hver diseases, givmg cause to the fears expiessed m
previous studies (5, 20) Additionally, since haemophihacs infected
by HIV, HBV and HCV are not uncommon (21), more deaths due to
combmed mfections may be expected for the near future
It has been previously reported (20, 22, 23) that patients with anti-
bodies have a higher nsk of dymg due to bleedmg than patients without
antibodies In this study, however, it seems that this is not the case Sui-
cide was the cause of death for 5% of both Bntish and Dutch haemo-
phihacs (20, 23), while a high peicentage was also reported from the
USA (6) We leport only one suicide of a 34-years-old Schizophrenie
patient This may reflect a low suicide täte m the Greek geneial popula-
tion Cause specific SMRs leveal that no excess mortality due to maiig
nancies is observed among Gieek haemophihacs, which is m good
agreement with other published studies (6, 20) äs well äs with a recent
survey in Dutch haemophihacs for the penod 1986-1992 (unpublished
data) Previously a substantial reduction (by 80%) of deaths due to
ischaemic heart disease was found in Dutch haemophilia patients (23),
which could not be explamed by differences m the presence of major
classical nsk factois (24) The conclusion that haemophilia and the le-
lated clotting defect offei protection agamst ischaemic heart disease is
supported by the present lesults m the Greek patients Cerebral hae
morrhage accounted for 29% of deaths among HIV(-) patients of this
study, which is similai to the figure found m the United Kingdom (20)
Among HIV(+) haemophihacs, however, the nsk of fatal cerebral
bleedmg appeais to be much higher
The mtention of this study was to estimate the past, leahze the pre-
sent and plan the futuie, äs well äs to piovtde a baselme foi forthcommg
comparative studies m the Greek haemophilia population No more
than a decade ago, the mdisputable improvements m haemophilia
management would have led similai studies to optimistic predictions
However, the shadows of viral mfections peimit at the present only
modest expectations, probably combmed with well founded feelmgs of
hope
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